The Hospital Research Foundation Group Impact Report - Flipbook - Page 22
CHILDHOOD CANCER
Childhood cancer is the most
devastating of all diseases.
Improving survival rates and long-term quality
of life for families hit by these horrible cancers
is vital. Thankfully you have made a remarkable
impact in 2023, with more still to come.
DID YOU
KNOW?
Adelaide will be the only
place in the southern
hemisphere to offer
proton therapy – a
precision treatment for
hard-to-access cancers.
YOUR IMPACT IN 2023:
Funding the specialist training and
preparation work for proton therapy
to be delivered to Australian children
from 2025
Starting human trials for a new
treatment called CAR T-cell therapy for
children with an incurable brain cancer
Enhancing follow-up care and quality
of life for children recovering from
radiotherapy
Supporting a world-leading paediatric
nuero-oncologist to deliver care in
Adelaide and prepare the state for
proton therapy
Investigating better treatments for
children with medulloblastoma.
Finding more targeted treatments
for children with neuroblastoma
Women’s &
Children’s Hospital
Central Adelaide
Local Health Network
Bringing research to human trials
A new treatment is now available for children with
an incurable brain cancer, thanks to your support.
For the first time, CAR T-cell therapy – which
involves genetically engineering a patient’s
cancer-fighting T-cells to create ‘supercharged’
CAR T-cells – has been trialled in Australian children
with Diffuse Intrinsic Pontine Glioma (DIPG).
“We have been working on this treatment for
the past four years so I am incredibly proud
that these young patients will finally benefit
from our innovative work here at the RAH,”
Professor Michael Brown said.
22 | The Hospital Research Foundation Group Impact Report 2023
How does CAR T-cell therapy
work? WATCH this animation!
